Sonendo

Sonendo is a commercial-stage MedTech company focused on saving teeth from tooth decay. The company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The GentleWave System utilizes a proprietary mechanism of action that combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics to debride and disinfect deep regions of the complex root canal system in a less-invasive procedure that preserves tooth structure.

Compared to conventional root canal therapy methods, the clinical benefits of the GentleWave System include improved outcomes, such as superior cleaning independent of root canal complexity and tooth anatomy, high and rapid healing rates, and minimal-to-no-postoperative pain. Additionally, the GentleWave System can streamline workflows and improve the economics of dental practices. 

As of December 2023, the GentleWave System's installed base was 1,134 units, representing growth of approximately 16% compared to December 2022. In March 2024, Sonendo divested its TDO Software segment by selling substantially all its assets and liabilities.

In November 2023, Sonendo was suspended from trading on the New York Stock Exchange due to non-compliance, and subsequently commenced trading on the OTCQX Best Market under the symbol "SONX." For FY2023, Sonendo reported a total revenue of USD 43.9 million, representing a growth of 5% YoY.

Key customers and partnerships

Sonendo has formed several key partnerships to advance its technology, including leading endodontic dental service organizations (DSOs) and expanding access to the GentleWave System for root canal therapy (October 2023). 

In January 2024, Sonendo partnered with BEST for Dentistry, a leading DSO. In the same month, it partnered with Dental Purchasing Group, expanding access to the GentleWave System for improved root canal therapy.